The hospital in the south-east of England has bought six CardioQ-ODM+ monitors and oesophageal probes in a purchase worth £30,000.
Its doctors demanded a replacement to equipment bought in 2013 through a NHS national programme.
While the order was not large enough to affect forecasts this year, it does reflect a generally improving UK performance in the second half of the year to date said Deltex.
Ewan Phillips chief executive, said it was encouraging that it was doctors insisting on its equipment.
Deltex has been hard hit by the cash crisis affecting the NHS but Phillips said today’s order was further evidence that, for the company anyway, the situation may be improving.
“Excellent results from the largest ever randomised controlled trial of ODM in June and the further presentation in July of a trial from a major NHS hospital confirming better comparative outcomes from using ODM during surgery," had also boosted sentiment, he added.